Baird Financial Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Baird Financial Group, Inc.

  • $50.2 Billion
  • Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 35,848 shares of REGN stock, worth $25.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
35,848
Previous 34,693 3.33%
Holding current value
$25.6 Million
Previous $36.5 Million 3.35%
% of portfolio
0.08%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $1.18 Million - $1.39 Million
1,155 Added 3.33%
35,848 $37.7 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $672,115 - $815,175
761 Added 2.24%
34,693 $36.5 Million
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $64,090 - $70,527
71 Added 0.21%
33,932 $32.7 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $197,670 - $224,833
255 Added 0.76%
33,861 $29.7 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $204,272 - $249,089
295 Added 0.89%
33,606 $27.7 Million
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $1.32 Million - $1.57 Million
1,885 Added 6.0%
33,311 $23.9 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $2.77 Million - $3.36 Million
-4,064 Reduced 11.45%
31,426 $25.8 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $850,049 - $1.07 Million
-1,481 Reduced 4.0%
35,514 $24.5 Million
Q2 2022

Aug 08, 2022
BUY
$548.35 - $738.84 $255,531 - $344,299
466 Added 1.28%
36,995 $21.9 Million
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $10.9 Million - $12.8 Million
18,345 Added 100.89%
36,529 $25.5 Million
Q4 2021

Feb 09, 2022
SELL
$543.48 - $670.97 $606,523 - $748,802
-1,116 Reduced 5.78%
18,184 $11.5 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $2.34 Million - $2.77 Million
4,073 Added 26.75%
19,300 $11.7 Million
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $1.16 Million - $1.37 Million
2,458 Added 19.25%
15,227 $8.51 Million
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $1.92 Million - $2.35 Million
4,293 Added 50.65%
12,769 $6.04 Million
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $209,973 - $266,903
439 Added 5.46%
8,476 $4.1 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $168,872 - $204,045
310 Added 4.01%
8,037 $4.5 Million
Q2 2020

Oct 22, 2020
SELL
$493.32 - $643.92 $396,135 - $517,067
-803 Reduced 9.41%
7,727 $2.13 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $228,900 - $298,778
464 Added 5.75%
8,530 $1.82 Million
Q1 2020

May 14, 2020
SELL
$336.18 - $494.43 $683,453 - $1.01 Million
-2,033 Reduced 20.13%
8,066 $3.94 Million
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $868,717 - $1.19 Million
-3,169 Reduced 23.88%
10,099 $3.79 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $2.24 Million - $2.61 Million
-8,199 Reduced 38.19%
13,268 $1.34 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $1.43 Million - $1.98 Million
4,766 Added 28.54%
21,467 $6.72 Million
Q1 2019

May 14, 2019
SELL
$372.08 - $439.57 $153,296 - $181,102
-412 Reduced 2.41%
16,701 $6.86 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $106,454 - $127,763
-317 Reduced 1.82%
17,113 $6.39 Million
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $139,051 - $161,769
-396 Reduced 2.22%
17,430 $6.94 Million
Q2 2018

Aug 13, 2018
BUY
$284.6 - $344.99 $221,703 - $268,747
779 Added 4.57%
17,826 $6.15 Million
Q1 2018

May 14, 2018
BUY
$315.82 - $393.78 $409,618 - $510,732
1,297 Added 8.23%
17,047 $5.87 Million
Q4 2017

Feb 09, 2018
BUY
$358.63 - $469.95 $761,012 - $997,233
2,122 Added 15.57%
15,750 $5.92 Million
Q3 2017

Nov 14, 2017
SELL
$431.38 - $504.0 $1.73 Million - $2.03 Million
-4,018 Reduced 22.77%
13,628 $6.09 Million
Q2 2017

Aug 14, 2017
BUY
N/A
17,646
17,646 $8.67 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email